AAPAN's VP of Government Affairs, Lisa Anne Hurt-Forsythe provided insight into the ramifications to the workers' comp industry if the FDA reschedules cannabis. AAPAN members were privy to an in-depth update webinar on this topic, and we will continue to keep our members abreast of any developments and impacts.
In the second half of the Joint Medical Issues and Research & Standards Committee Meeting, #IAIABC110 attendees had a rousing group discussion on the potential implications for the #workerscomp industry if cannabis ends up being rescheduled by the FDA.